H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens

Biochemical and Biophysical Research Communications

Volumn 372, Issue 2, 2008, Pages 293-297

  Li, Chengjun ^a   Ping, Jihui ^a   Jing, Bo ^a   Deng, Guohua ^a   Jiang, Yongping ^a   Li, Yanbing ^a   Tian, Guobin ^a   Yu, Kangzhen ^a   Bu, Zhigao ^a   Chen, Hualan ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Avian influenza; H5N1; Marker vaccine

Indexed keywords

INFLUENZA VACCINE; SIALIDASE;

ANTIBODY RESPONSE; ARTICLE; CHICKEN; DRUG EFFICACY; ENZYME ASSAY; IMMUNOGENICITY; INFLUENZA; INFLUENZA VIRUS A H5N1; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; VIROGENESIS; VIRUS CHARACTERIZATION; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHICKENS; GLYCOPROTEINS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MURINE HEPATITIS VIRUS; NEURAMINIDASE; VACCINATION; VACCINES, DNA; VACCINES, INACTIVATED; VIRAL PROTEINS; VIRUS REPLICATION;

AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS; MURINE HEPATITIS VIRUS;

EID: 44649103220     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.05.057     Document Type: Article

References (18)

1. Capua I., and Alexander D.J. Avian influenza: recent developments. Avian Pathol. 33 (2004) 393-404
2. C.C. Villareal, C.E. Rivera, An update on avian influenza in Mexico, in: Proceedings of the 5th International Symposium on Avian Influenza, Georgia, USA, 2002, pp. 14-17.
3. K. Naeem, The avian influenza H7N2 outbreak in south central Asia, in: Proceedings of the 4th International Symposium on Avian Influenza, 1998, pp. 31-35.
4. Tian G., Zhang S., Li Y., Bu Z., Liu P., Zhou J., Li C., Shi J., Yu K., and Chen H. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 341 (2005) 153-162
5. Babiuk L.A. Broadening the approaches to developing more effective vaccines. Vaccine 17 (1999) 1587-1595
6. Li S., Liu C., Klimov A., Subbarao K., Perdue M.L., Mo D., Ji Y., Woods L., Hietala S., and Bryant M. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179 (1999) 1132-1138
7. Subbarao K., Chen H., Swayne D., Mingay L., Fodor E., Brownlee G., Xu X., Lu X., Katz J., Cox N., and Matsuoka Y. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305 (2003) 192-200
8. Li Z., Chen H., Jiao P., Deng G., Tian G., Li Y., Hoffmann E., Webster R.G., Matsuoka Y., and Yu K. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J. Virol. 79 (2005) 12058-12064
9. Hoffmann E., Neumann G., Kawaoka Y., Hobom G., and Webster R.G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97 (2000) 6108-6113
10. Neumann G., Watanabe T., Ito H., Watanabe S., Goto H., Gao P., Hughes M., Perez D.R., Donis R., Hoffmann E., Hobom G., and Kawaoka Y. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. USA 96 (1999) 9345-9350
11. Fodor E., Devenish L., Engelhardt O.G., Palese P., Brownlee G.G., and Garcia-Sastre A. Rescue of influenza A virus from recombinant DNA. J. Virol. 73 (1999) 9679-9682
12. O.I.d. Epizooties, OIE manual of diagnostic tests and vaccines for terrestrial animals, Office International des Epizooties, Paris, France, 2004.
13. Garcia A., Johnson H., Srivastava D.K., Jayawardene D.A., Wehr D.R., and Webster R.G. Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection. Avian Dis. 42 (1998) 248-256
14. Mebatsion T., Koolen M.J., de Vaan L.T., de Haas N., Braber M., Romer-Oberdorfer A., van den Elzen P., and van der Marel P. Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope. J. Virol. 76 (2002) 10138-10146
15. Chen H., Deng G., Li Z., Tian G., Li Y., Jiao P., Zhang L., Liu Z., Webster R.G., and Yu K. The evolution of H5N1 influenza viruses in ducks in southern China. Proc. Natl. Acad. Sci. USA 101 (2004) 10452-10457
16. Chen H., Li Y., Li Z., Shi J., Shinya K., Deng G., Qi Q., Tian G., Fan S., Zhao H., Sun Y., and Kawaoka Y. Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J. Virol. 80 (2006) 5976-5983
17. Castrucci M.R., Hou S., Doherty P.C., and Kawaoka Y. Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes. J. Virol. 68 (1994) 3486-3490
18. Castrucci M.R., Bilsel P., and Kawaoka Y. Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. J. Virol. 66 (1992) 4647-4653